FOLFIRINOX in locally advanced and metastatic pancreatic cancer: A single centre cohort study

Journal of Cancer

Volumn 7, Issue 13, 2016, Pages 1861-1866

  Rombouts, S J ^a,b   Mungroop, T H ^a   Heilmann, M N ^a   van Laarhoven, H W ^a   Busch, O R ^a   Molenaar, I Q ^a,b   Besselink, M G ^a   Wilmink, J W ^a  

^a ACADEMIC MEDICAL CENTER   (Netherlands)

^b UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

Advanced stage; Efficacy; FOLFIRINOX; Pancreatic cancer; Stage III and IV; Toxicity

Indexed keywords

FLUOROURACIL; FOLINIC ACID; GEMCITABINE; IRINOTECAN; OXALIPLATIN;

ADULT; ADVANCED CANCER; AGED; ALOPECIA; ARTICLE; BOLUS INJECTION; CANCER COMBINATION CHEMOTHERAPY; CANCER LOCALIZATION; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CLINICAL ARTICLE; COHORT ANALYSIS; CONSOLIDATION CHEMOTHERAPY; CONSTIPATION; DIARRHEA; DISTANT METASTASIS; DOSE RESPONSE; DRUG DOSE REDUCTION; DRUG EFFICACY; DRUG TOLERABILITY; FATIGUE; FEBRILE NEUTROPENIA; FEMALE; HAND FOOT SYNDROME; HUMAN; INOPERABLE CANCER; MALE; MONOTHERAPY; MUCOSA INFLAMMATION; NAUSEA; NEUROPATHY; NEUTROPENIA; OVERALL SURVIVAL; PAIN; PANCREAS CANCER; PROGRESSION FREE SURVIVAL; RETROSPECTIVE STUDY; SENSORY NEUROPATHY; THROMBOCYTOPENIA; TOXICITY TESTING; TREATMENT RESPONSE; TUMOR ABLATION; VOMITING; WORLD HEALTH ORGANIZATION;

EID: 85003846548     PISSN: None     EISSN: 18379664     Source Type: Journal    
DOI: 10.7150/jca.16279     Document Type: Article

References (16)

1. [Internet] National Cancer Institute: Pancreatic Cancer Facts; Revised 5 February 2016. http://seer.cancer.gov/statfacts/html/pancreas.html
2. Ferlay J, Steliarova-Foucher E, Lortet-Tieulent J, et al. Cancer incidence and mortality patterns in Europe: estimates for 40 countries in 2012. Eur J Cancer. 2013 Apr; 49(6):1374-403.
3. [Internet] Oncoline: Pancreatic cancer; Revised 5 February 2016. http://www.oncoline.nl/pancreascarcinoom
4. Burris HA, 3rd, Moore MJ, Andersen J, et al. Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial. J Clin Oncol. 1997; 15: 2403-13.
5. Conroy T, Desseigne F, Ychou M, et al. FOLFIRINOX versus gemcitabine for metastatic pancreatic cancer. N Engl J Med. 2011; 364: 1817-25.
6. Petrelli F, Coinu A, Borgonovo K, et al. FOLFIRINOX-based neoadjuvant therapy in borderline resectable or unresectable pancreatic cancer: a meta-analytical review of published studies. Pancreas. 2015; 44: 515-21.
7. [Internet] Definitions of resectability according to the Dutch Pancreatic Cancer Group; available at www.dpcg.nl and in the study protocol of the Pancreatic Locally advanced Irresectable Cancer Ablation in the Netherlands (PELICAN) trial, available at the Dutch Trial Register under number 5517. http://www.trialregister.nl/trialreg/admin/rctview.asp?TC=5517.
8. National Cancer Institute. Common Terminology Criteria for Adverse Events (CTCAE) version 4.0, May 2009
9. Schemper M, Smith TL. A note on quantifying follow-up in studies of failure time. Control Clin Trials. 1996; 17: 343-46
10. Rombouts SJ, Walma MS, Vogel JA, et al. Systematic Review of Resection Rates and Clinical Outcomes After FOLFIRINOX-Based Treatment in Patients with Locally Advanced Pancreatic Cancer. Ann Surg Oncol. 2016 Jul 1. [Epub ahead of print]
11. He J, Page AJ, Weiss M, et al. Management of borderline and locally advanced pancreatic cancer: where do we stand? World J Gastroenterol. 2014 Mar 7; 20(9): 2255-66.
12. Marthey L, Sa-Cunha A, Blanc JF, et al. FOLFIRINOX for locally advanced pancreatic adenocarcinoma: results of an AGEO multicenter prospective observational cohort. Ann Surg Oncol. 2015; 22: 295-301.
13. Sadot E, Doussot A, O'Reilly EM, et al. FOLFIRINOX Induction Therapy for Stage 3 Pancreatic Adenocarcinoma. Ann Surg Oncol. 2015; 22: 3512-21.
14. [Internet] National Comprehensive Cancer Network. NCCN guidelines version 2. 2015. Pancreatic Adenocarcinoma; 2015. http://www.tri-kobe.org/nccn/guideline/pancreas/english/pancreatic.pdf
15. Ferrone CR, Marchegiani G, Hong TS, et al. Radiological and surgical implications of neoadjuvant treatment with FOLFIRINOX for locally advanced and borderline resectable pancreatic cancer. Ann Surg. 2015; 261: 12-17.
16. [Internet] Dutch Trial Register Number (NTR) 5517. http://www.trialregister.nl/trialreg/admin/rctview.asp?TC=5517